The 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology is holding their annual meeting at the Grand America this week. This is the first time the meeting has been held in Salt Lake City.

The IATDMCT has drawn 500 scientists from around the world to exchange ideas and experience. There are over 30 countries represented at this years’ event which is specifically designed to showcase at least two countries in each working session. Carol George, State Science Advisor and Kevin Jessing, Life Science Cluster Director, stopped into the conference to discuss its relevance with co-chairs Gwen McMillin, Medical Director, Toxicology at ARUP and William Clarke from Johns Hopkins. Utah has an incredible diagnostics community. and the city is the ideal meeting place for international travelers. “I was sold on Salt Lake when I saw it in person”, says William Clarke. I addition to the great scientific discussions taking place at the conference, organizers worked directly with the Utah Office of Tourism so conference attendees would have ample opportunity to see the city by bus and bike while in town.

Below, Kevin Jessing, Life Science Cluster Director, discusses Waters Corporation’s new q-TOF instrument with Steve Griffin. Waters recently installed a similar instrument at the Waters Advanced Mass Spectrometry Lab at the University of Utah.